Global Autologous Cell Therapy Market Research Report 2017 to 2021 provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure of the Autologous Cell Therapy Market.
Companies Mentioned are Brainstorm Cell Therapeutics, Holostem Advanced Therapies, Osiris Therapeutics, Valeant, Vericel, AbbVie, American CryoStem, AM-Pharma, Anterogen, apceth Biopharma, Astellas Pharma, Athersys, Baxter International, Beike Biotechnology, BIOTIME, bluebird bio, Bristol-Myers Squibb, Brainxell, Caladrius Biosciences, Cellular Biomedicine, Cellular Dynamics International, Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, Citospin, Corestem, Cytori Therapeutics, Daiichi Sankyo, Fujifilm, Gamida Cell, Global Stem Cells, Grupo Ferrer Internacional, GlaxoSmithKline, Hemostemix, Histocell, International Stem Cell, Ivy Institute of Stem Cells, Japan Regenerative Medicine, Kangstem Biotech, Kiadis Pharma, Laboratorios Salvat, MEDIPOST, Mesoblast, Nuo Therapeutics, Opsis Therapeutics, Pharmicell, Pluristem Therapeutics, Promethera Biosciences, Q Therapeutics, ReNeuron, RHEACELL, Salus Medical Solutions, Sangamo Therapeutics, Shire, Steminent Biotherapeutics, Sumitomo Dainippon Pharma, Taiwan Bio Therapeutics, Takeda Pharmaceutical, Teva Pharmaceutical Industries, Thoratec, TiGenix, Translational Biosciences, TWO CELLS, U.S. Stem Cell, ViaCyte, and VistaGen Therapeutics.
The global Autologous Cell Therapy market consists of different international, regional, and local vendors. The market competition is foreseen to grow higher with the rise in technological innovation and M&A activities in the future. Moreover, many local and regional vendors are offering specific application products for varied end-users. The new vendor entrants in the market are finding it hard to compete with the international vendors based on quality, reliability, and innovations in technology.
Major points covered in Global Autologous Cell Therapy Market 2017 Research are:-
- What will the market size and the growth rate be in 2021?
- What are the key factors driving the global Autologous Cell Therapy market?
- What are the key market trends impacting the growth of the global Autologous Cell Therapy market?
- What are the challenges to market growth?
- Who are the key vendors in the global Autologous Cell Therapy market?
- What are the market opportunities and threats faced by the vendors in the global Autologous Cell Therapy market?
- Trending factors influencing the market shares of the Americas, APAC, and EMEA.
- What are the key outcomes of the five forces analysis of the global Autologous Cell Therapy market?
This independent 70 page report guarantees you will remain better informed than your competition. With over 160 tables and figures examining the Autologous Cell Therapy market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leader’s market revenue forecasts as well as analysis to 2021.
Get a Sample copy of this report at
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Autologous Cell Therapy in these regions, from 2012 to 2021 (forecast), covering Americas, APAC and EMEA.
The report provides a basic overview of the Autologous Cell Therapy industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Autologous Cell Therapy industry development trends and marketing channels are analyzed.
Commenting on the report, an analyst from MIR’s team said: “The latest trend gaining momentum in the market is private funding will fuel market growth. The increasing investments from private enterprises will likely change the market dynamics. Many vendors are investing in production or manufacturing facilities to improve their production or manufacturing expertise. They are also focusing on establishing new business units or companies to penetrate the market further.”
According to the report, one of the major drivers for this market is increasing demand for effective drugs for cardiac and degenerative disorders. There has been an increased demand for providing effective drugs for cardiac and degenerative disorders globally. Prior to the advent of autologous cell therapies, there was no effective drug to repair a damaged heart. The discovery of possible cardiac autologous cells opened new possibilities for repairing damaged cardiac tissue caused by acute myocardial infarction or coronary artery disease.
Further, the report states that one of the major factors hindering the growth of this market is critical ethical challenges with respect to stem cell research. Over the years, there has been a continuous debate over ethical issues related to stem cell therapy. Embryonic stem cell development is continuously debated upon by scientists and policy makers. The use of human embryonic stem cells in research has always concerned decision makers and the scientific fraternity. Some of the issues include the cloning of embryonic stem cells and the destruction of embryos to create cell lines.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The research includes historic data from 2012 to 2016 and forecasts until 2021 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs. The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation and future development trend of Autologous Cell Therapy on the basis of stating current situation of the industry in 2017 so as to make comprehensive organization and judgment on the competition situation and development trend of Autologous Cell Therapy Market and assist manufacturers and investment organization to better grasp the development course of Autologous Cell Therapy Market.
Browse full report at